This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

In addition to its robust preclinical pipeline of PROTAC® protein degraders against validated and "undruggable" targets, the ...

"We are particularly worried about Haiti, Kenya, Lesotho, South Sudan, Burkina Faso, Mali, Nigeria, and Ukraine, where ARV disruptions could have severe ... AllAfrica publishes around 500 reports a ...

providing life-saving treatments like antiretroviral therapy (ARV), and advancing medical research in Africa and other low -- ...

Big pharma's interest in using protein degradation as a therapeutic strategy continues with a wide-ranging deal between Pfizer and US biotech Triana Biomedicines that could be worth $1.5 billion ...

Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bengaluru, India. The Company mainly operates in the regulated markets including key markets of US, Europe ...

Chandigarh admn imposes up to 200% jump in tax for both residential and commercial properties to drive up cash-strapped MC’s revenue by ₹54 crore annually After imposing a significant hike in ...

Net loss: AU$5.65m (loss widened by 209% from 1H 2024). AU$0.003 loss per share (further deteriorated from AU$0.001 loss in 1H 2024). It's necessary to consider the ever-present spectre of ...

Pipeline and key clinical candidates for these companies: Arvinas is a clinical-stage biotechnology company that says it is “dedicated to improving the lives of patients suffering from ...

Goldman Sachs says flying ASX gold equities could go higher still even as they outpace bullion in 2025, with margins expanding.